Registered with SAHPRA

Mounjaro prices in South Africa

Mounjaro contains tirzepatide, made by Eli Lilly — a "dual agonist" that acts on both GIP and GLP-1 receptors, a different mechanism from semaglutide-based medications. It's taken as a once-weekly injection and is registered in South Africa for type 2 diabetes management. Below, current listed prices by dose across the providers we track.

See prices by dose How it works

Price comparison

Mounjaro, by dose and provider

Sample data for site review. Figures are illustrative and will be replaced with verified provider pricing before launch.

Dose	Provider	Type	Price	Stock
2.5 mg starter dose	Provider B	Pharmacy	R2 150	In stock
5 mg	Provider B	Pharmacy	R2 780	In stock
7.5 mg	Provider B	Pharmacy	R3 920	In stock
10 mg	Provider D	Telehealth	R4 610	Limited
15 mg highest available dose	Provider B	Pharmacy	R5 380	In stock

Prices reflect provider list prices in ZAR and exclude consultation fees. Always confirm current pricing directly with the provider before purchase. See our verification methodology.

What is Mounjaro?

Mounjaro is the brand name for tirzepatide, sometimes called a "twincretin" because it activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors — unlike Ozempic, Wegovy and Saxenda, which act on GLP-1 alone. This dual mechanism is one reason it's often discussed alongside, rather than simply grouped with, other GLP-1 medications.

In South Africa, Mounjaro is registered for managing type 2 diabetes. Internationally, tirzepatide is also marketed under a separate brand for weight management; that distinct weight-management registration is not the focus of this page.

Different mechanism, similar comparison basis

Because tirzepatide works differently to semaglutide and liraglutide, your doctor may recommend it over other options for specific health reasons — this is a clinical decision, not a pricing one.

Related medications

You may also want to compare Ozempic or Wegovy (semaglutide-based), or Saxenda (an older, daily GLP-1 injection).